miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism

被引：0
|
作者：
Huihui Gao
Zhaofeng Gao
Xiaobei Liu
Xu Sun
Zhonghui Hu
Zhengwei Song
Cheng Zhang
Jianguo Fei
Xiaoguang Wang
机构：
[1] The No.1 People’s Hospital of Pinghu City,Department of Internal Medicine
[2] The Second Affiliated Hospital of Jiaxing University,Department of Surgery
[3] Zhejiang Chinese Medical University,Faculty of Graduate Studies
[4] Huzhou Central Hospital,School of Medicine
[5] Affiliated Huzhou Hospital,Department of Hepatobiliary and Pancreatic Surgery
[6] Zhejiang University,undefined
[7] The First Affiliated Hospital,undefined
[8] Zhejiang University School of Medicine,undefined
来源：
Cell Division | / 19卷
关键词：
PDZK1; miR-101-3p; Hepatocellular carcinoma; PI3K/AKT; Cell proliferation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism
    Gao, Huihui
    Gao, Zhaofeng
    Liu, Xiaobei
    Sun, Xu
    Hu, Zhonghui
    Song, Zhengwei
    Zhang, Cheng
    Fei, Jianguo
    Wang, Xiaoguang
    CELL DIVISION, 2024, 19 (01)
  • [2] Sortilin 1 regulates hepatocellular carcinoma progression by activating the PI3K/AKT signaling
    Ye, S.
    Wang, B.
    Zhou, Y.
    Sun, Q.
    Yang, X.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [3] The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
    Tian, Ling-Yu
    Smit, Daniel J.
    Juecker, Manfred
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [4] MiR-92a-3p Promotes the Malignant Progression of Hepatocellular Carcinoma by Mediating the PI3K/AKT/mTOR Signaling Pathway
    Wang, Libing
    Cui, Mingxin
    Qu, Fengzhi
    Cheng, Daming
    Yu, Jingkun
    Tang, Zhaoyuan
    Cheng, Ling
    Wei, Yanbing
    Wu, Xiaotang
    Liu, Xiaogang
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (29) : 3244 - 3250
  • [5] Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer
    Zhao, Chunjuan
    Tao, Tao
    Yang, Longyan
    Qin, Qiong
    Wang, Ying
    Liu, Hua
    Song, Ran
    Yang, Xiaomei
    Wang, Qiqi
    Gu, Siyu
    Xiong, Ying
    Zhao, Dong
    Wang, Songlin
    Feng, Duiping
    Jiang, Wen G.
    Zhang, Jun
    He, Junqi
    CANCER LETTERS, 2019, 453 : 107 - 121
  • [6] MiR-660-5p promotes the progression of hepatocellular carcinoma by interaction with YWHAH via PI3K/Akt signaling pathway
    Wu, Yunyu
    Zhang, Yan
    Wang, Feng
    Ni, Qingfeng
    Li, Mei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 531 (04) : 480 - 489
  • [7] Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma
    Rahmani, Farzad
    Ziaeemehr, Aghigh
    Shahidsales, Soodabeh
    Gharib, Masoumeh
    Khazaei, Majid
    Ferns, Gordon A.
    Ryzhikov, Mikhail
    Avan, Amir
    Hassanian, Seyed M.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (05) : 4146 - 4152
  • [8] Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
    Yu, Xinxin
    Zheng, Yan
    Zhu, Xuchao
    Gao, Xiaomei
    Wang, Chaoqun
    Sheng, Yuanyuan
    Cheng, Wei
    Qin, Lunxiu
    Ren, Ning
    Jia, Huliang
    Dong, Qiongzhu
    ONCOLOGY LETTERS, 2018, 16 (04) : 5299 - 5308
  • [9] Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
    Wang, Houhong
    Chen, Wenli
    Cui, Yayun
    Gong, Huihui
    Tang, Amao
    AGING-US, 2023, 15 (15): : 7831 - 7843
  • [10] Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
    Bang, Jieun
    Jun, Mihyeon
    Lee, Soyun
    Moon, Hyuk
    Ro, Simon Weonsang
    PHARMACEUTICS, 2023, 15 (08)
12345